Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant.

European journal of human genetics : EJHG - 1 Apr 2020

Tan Clara S H, Ang Su Fen, Lim Su Chi

Abstract excerpt

Maturity-onset diabetes of the young (MODY) is a genetically and clinically heterogeneous group of disorders characterised by early onset, lean, non-autoimmunity mediated, non-insulin-dependent diabetes often with autosomal-dominant inheritance and specific pharmaco-genetic response. We describe two siblings with HNF1A-MODY (MODY3) due to a novel germline variant p.(His126Asp) which segregates with diabetes in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Hepatocyte Nuclear Factor 1-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Mutation

Share to Pedigree

Share to Pharmacogenomic Variants

Share to Sulfonylurea Compounds

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 31844173
DOI: 10.1038/s41431-019-0561-8
PMCID: PMC7080716

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant.PMID 31844173Read ↗

A family with a novel termination mutation in hepatic nuclear factor 1α in maturity-onset diabetes of the young type 3 which is unresponsive to sulphonylurea therapy.Semantic proximity Read ↗

Divergent phenotypes in siblings with identical novel mutations in the HNF-1α gene leading to maturity onset diabetes of the young type 3.Semantic proximity Read ↗

[A Dutch family with an autosomal dominant form of diabetes mellitus as a result of a mutation in the HNF1 alpha-gene (MODY3)].Semantic proximity Read ↗

Mody-3: novel HNF1A mutation and the utility of glucagon-like peptide (GLP)-1 receptor agonist therapy.Semantic proximity Read ↗

An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?Semantic proximity Read ↗

Treatment implications of a delayed diagnosis of maturity-onset diabetes of the young.Semantic proximity Read ↗

[MODY 3 correlations between the genotype and clinical manifestations of diabetes].Semantic proximity Read ↗

[Glibenclamide instead of insulin: a new chance for MODY 3 type diabetes patients: case report].Semantic proximity Read ↗

Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report.Semantic proximity Read ↗

Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing.Semantic proximity Read ↗

Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes.Semantic proximity Read ↗

Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.